$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000101008618000014 Filed on November 06, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$1.569M	$471.1M	$1.390M
YoY Change	11.12%	33790.29%	-70.43%
Cost Of Revenue	$103.0K	$95.17M	$0.00
YoY Change
Gross Profit	$1.466M	$375.9M	$1.390M
YoY Change		26943.81%
Gross Profit Margin	93.44%	79.8%	100.0%
Selling, General & Admin	$3.828M	$3.115M	$3.094M
YoY Change	16.67%	0.68%	8.37%
% of Gross Profit	261.12%	0.83%	222.59%
Research & Development	$2.973M	$3.723M	$2.471M
YoY Change	6.9%	50.67%	-59.28%
% of Gross Profit	202.8%	0.99%	177.77%
Depreciation & Amortization	$20.00K	$14.71K	$29.38K
YoY Change	0.0%	-49.92%	-31.14%
% of Gross Profit	1.36%	0.0%	2.11%
Operating Expenses	$6.801M	$102.2M	$7.041M
YoY Change	12.19%	1351.35%	-44.65%
Operating Profit	-$5.541M	$368.9M	-$5.651M
YoY Change	13.75%	-6627.78%	-29.91%
Interest Expense	-$5.600M	$3.924M	$3.737M
YoY Change	-29.11%	5.0%	3843.17%
% of Operating Profit		1.06%
Other Income/Expense, Net	$78.80M	$5.067K	$2.021K
YoY Change		150.72%	-93.43%
Pretax Income	$67.60M	$362.6M	$9.700M
YoY Change	-632.28%	3638.53%	5.43%
Income Tax	$15.20M	-$25.41M	$134.7K
% Of Pretax Income	22.49%	-7.01%	1.39%
Net Earnings	$52.39M	$388.1M	-$9.816M
YoY Change	-608.5%	-4053.24%	6.19%
Net Earnings / Revenue	3339.13%	82.38%	-706.19%
Basic Earnings Per Share	$0.65	$4.85	-$0.12
Diluted Earnings Per Share	$0.65	$4.71	-$0.12
COMMON SHARES
Basic Shares Outstanding	80.32M shares	80.02M shares	78.91M shares
Diluted Shares Outstanding		82.93M shares	78.91M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.7M	$104.0M	$25.80M
YoY Change	406.03%	303.1%	25.85%
Cash & Equivalents	$100.7M	$104.0M	$25.80M
Short-Term Investments
Other Short-Term Assets	$15.80M	$5.200M	$11.50M
YoY Change	24.41%	-54.78%	19.79%
Inventory	$2.908M	$2.908M	$2.983M
Prepaid Expenses
Receivables	$1.959M	$1.540M	$612.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$121.3M	$113.7M	$40.89M
YoY Change	224.61%	177.94%	-52.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$171.3K	$117.9K	$119.7K
YoY Change	23.54%	-1.56%	-63.73%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.059M	$1.095M	$642.1K
YoY Change	50.8%	70.57%	0.0%
Total Long-Term Assets	$82.15M	$30.06M	$107.8M
YoY Change	-23.44%	-72.12%	41.4%
TOTAL ASSETS
Total Short-Term Assets	$121.3M	$113.7M	$40.89M
Total Long-Term Assets	$82.15M	$30.06M	$107.8M
Total Assets	$203.4M	$143.7M	$148.7M
YoY Change	40.63%	-3.36%	-8.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.688M	$894.8K	$1.362M
YoY Change	27.06%	-34.32%	-53.43%
Accrued Expenses	$9.649M	$4.311M	$4.321M
YoY Change	76.02%	-0.23%	-9.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.34M	$5.206M	$13.04M
YoY Change	66.47%	-60.07%	-87.96%
LONG-TERM LIABILITIES
Long-Term Debt	$75.50M	$74.40M	$69.90M
YoY Change	6.19%	6.44%
Other Long-Term Liabilities	$13.60M	$11.60M	$378.3M
YoY Change	-96.51%	-96.93%	2.97%
Total Long-Term Liabilities	$89.10M	$86.00M	$448.2M
YoY Change	-80.67%	-80.81%	21.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.34M	$5.206M	$13.04M
Total Long-Term Liabilities	$89.10M	$86.00M	$448.2M
Total Liabilities	$100.5M	$91.25M	$461.6M
YoY Change	-78.51%	-80.23%	-3.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$115.8M	-$168.2M	-$527.1M
YoY Change	-78.45%	-68.09%	7.41%
Common Stock	$218.7M	$220.7M	$214.2M
YoY Change	2.09%	2.99%	20.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$102.9M	$52.47M	-$312.8M
YoY Change
Total Liabilities & Shareholders Equity	$203.4M	$143.7M	$148.7M
YoY Change	40.63%	-3.36%	-8.67%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$52.39M	$388.1M	-$9.816M
YoY Change	-608.5%	-4053.24%	6.19%
Depreciation, Depletion And Amortization	$20.00K	$14.71K	$29.38K
YoY Change	0.0%	-49.92%	-31.14%
Cash From Operating Activities	-$3.590M	$86.21M	-$7.620M
YoY Change	-56.0%	-1231.36%	-86.45%
INVESTING ACTIVITIES
Capital Expenditures	-$70.00K	$0.00	-$10.00K
YoY Change	40.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$78.34M
YoY Change
Cash From Investing Activities	$78.27M	$0.00	-$10.00K
YoY Change	-156640.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.350M	-1.450M	0.000
YoY Change	591.18%		-100.0%
NET CHANGE
Cash From Operating Activities	-3.590M	86.21M	-7.620M
Cash From Investing Activities	78.27M	0.000	-10.00K
Cash From Financing Activities	-2.350M	-1.450M	0.000
Net Change In Cash	72.33M	84.76M	-7.630M
YoY Change	-945.96%	-1210.88%	-86.74%
FREE CASH FLOW
Cash From Operating Activities	-$3.590M	$86.21M	-$7.620M
Capital Expenditures	-$70.00K	$0.00	-$10.00K
Free Cash Flow	-$3.520M	$86.21M	-$7.610M
YoY Change	-56.6%	-1232.85%	-86.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80320535	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Trading Symbol TradingSymbol	SIGAQ
CY2018Q3	siga	Amount Received From Contractfor Developmentand Support Activities AmountReceivedFromContractforDevelopmentandSupportActivities	43800000	USD
CY2017Q4	siga	Computer Equipment ComputerEquipment	701762	USD
CY2018Q3	siga	Computer Equipment ComputerEquipment	558118	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2018Q3	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	577000000	USD
CY2011Q2	siga	Contract Value Of Development And Support Activities ContractValueOfDevelopmentAndSupportActivities	48900000	USD
CY2018Q3	siga	Contract Value Of Development And Support Activities ContractValueOfDevelopmentAndSupportActivities	32000000	USD
CY2018Q3	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Manufacturingand Delivery Activities ContractValueofManufacturingandDeliveryActivities	459800000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	72700000	USD
CY2017Q3	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-295771	USD
CY2017Q3	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-300000	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-627624	USD
CY2018Q3	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-2300000	USD
CY2018Q3	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-2328674	USD
	siga	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	-5271503	USD
CY2018Q3	siga	Discrete Tax Benefit DiscreteTaxBenefit	25800000	USD
	siga	Discrete Tax Benefit DiscreteTaxBenefit	25800000	USD
CY2018Q3	siga	Government Contract Base Valueof Award For Deliveryof Courses GovernmentContractBaseValueofAwardForDeliveryofCourses	11100000	USD
CY2011Q2	siga	Government Contract Number Of Courses Purchased Under Modified Contract GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract	1700000	contract
	siga	Government Contract Number Of Courses Purchased Under Modified Contract GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract	1700000	contract
CY2018Q3	siga	Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance	3200000	USD
CY2018Q3	siga	Government Contract Paymentsfor Supportive Procurement Activities GovernmentContractPaymentsforSupportiveProcurementActivities	600000	USD
CY2018Q3	siga	Government Contract Proceedsfrom Paymentsfor Courses GovernmentContractProceedsfromPaymentsforCourses	629000000	USD
CY2011Q2	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	508700000	USD
CY2018Q3	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	628700000	USD
CY2018Q3	siga	Governmentcontractbasevalueawardfordeliveryandsupportactivities Governmentcontractbasevalueawardfordeliveryandsupportactivities	51700000	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	627624	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	5271503	USD
	siga	Inventory Write Downs InventoryWriteDowns	686000	USD
CY2016	siga	Milestone Payment MilestonePayment	20500000	USD
	siga	Net Realizationof Deferred Revenueand Costs Dueto Fda Approval NetRealizationofDeferredRevenueandCostsDuetoFDAApproval	0	USD
	siga	Net Realizationof Deferred Revenueand Costs Dueto Fda Approval NetRealizationofDeferredRevenueandCostsDuetoFDAApproval	281950853	USD
CY2011Q2	siga	Number Of Courses To Be Delivered1 NumberOfCoursesToBeDelivered1	2000000	course
CY2018Q3	siga	Number Of Courses To Be Delivered1 NumberOfCoursesToBeDelivered1	1488000	course
CY2018Q3	siga	Numberof Courses Delivered Options Final Drug Product NumberofCoursesDeliveredOptionsFinalDrugProduct	35700	course
CY2018Q3	siga	Numberof Courses Options Final Drug Product NumberofCoursesOptionsFinalDrugProduct	20000	course
	siga	Numberof Courses Options Final Drug Product NumberofCoursesOptionsFinalDrugProduct	64000	course
CY2018Q3	siga	Numberof Courses Storedas Vendor Managed Inventory NumberofCoursesStoredasVendorManagedInventory	212000	course
CY2018Q3	siga	Numberof Primary Manufacturing Steps NumberofPrimaryManufacturingSteps	2	step
CY2018Q3	siga	Numberofcoursesbasefinaldrugproduct Numberofcoursesbasefinaldrugproduct	8000000	USD
CY2017Q3	siga	Patent Preparation Fees PatentPreparationFees	250857	USD
	siga	Patent Preparation Fees PatentPreparationFees	688471	USD
CY2018Q3	siga	Patent Preparation Fees PatentPreparationFees	186028	USD
	siga	Patent Preparation Fees PatentPreparationFees	582833	USD
CY2018Q3	siga	Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts	459800000	USD
	siga	Reclassof Warrant Liabilitiesto Additional Paidin Capital Upon Exercise ReclassofWarrantLiabilitiestoAdditionalPaidinCapitalUponExercise	0	USD
	siga	Reclassof Warrant Liabilitiesto Additional Paidin Capital Upon Exercise ReclassofWarrantLiabilitiestoAdditionalPaidinCapitalUponExercise	6007847	USD
CY2018Q3	siga	Revenue Government Contract RevenueGovernmentContract	91000000	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	3363712	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	3363712	USD
CY2018Q3	siga	Stock Issued During Period Shares Exerciseof Warrants StockIssuedDuringPeriodSharesExerciseofWarrants	760000	shares
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1328867	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	894792	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1802107	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1539538	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2538340	USD
CY2018Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1284707	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5481579	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4310917	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	381980	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	411290	USD
CY2017Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	328588	USD
CY2018Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	323651	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3346738	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3223870	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	214229581	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	220647968	USD
CY2017Q4	us-gaap	Assets Assets	144670379	USD
CY2018Q3	us-gaap	Assets Assets	143727321	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	37364493	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	113663346	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28701824	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25798125	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103985265	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56174046	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45636951	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	8032	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	378896803	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	684232	USD
	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	-376432521	USD
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	-1780050	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108080634	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10537095	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	70979048	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79160058	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79160058	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79160058	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79160058	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	7904	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	95166271	USD
	us-gaap	Cost Of Revenue CostOfRevenue	95166271	USD
CY2018Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-25412994	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-25412497	USD
CY2017Q4	us-gaap	Deferred Costs DeferredCosts	96592334	USD
CY2018Q3	us-gaap	Deferred Costs DeferredCosts	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20383	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25520615	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1255318	USD
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	684232	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	377641485	USD
CY2018Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	2431963	USD
CY2018Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	27952578	USD
CY2017Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29375	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	105212	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	105000	USD
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14710	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48639	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.64
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	5271503	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11466162	USD
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10729818	USD
CY2017Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	363588	USD
CY2018Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	363588	USD
CY2017Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225421	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1225421	USD
CY2018Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2018Q3	us-gaap	Goodwill Goodwill	898334	USD
CY2018Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	362620225	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	343987202	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9681710	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-25590198	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	362637418	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	344004396	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134668	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	342563	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25412995	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25412498	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1719229	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1033651	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2542204	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-369872	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	24091967	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	9963188	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22690715	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	393032	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-199501	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	63700	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	137970	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-960074	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2906432	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3093854	shares
CY2017Q3	us-gaap	Interest Expense InterestExpense	3737175	USD
CY2017Q4	us-gaap	Liabilities Liabilities	467808670	USD
CY2018Q3	us-gaap	Liabilities Liabilities	91253516	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	144670379	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143727321	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6810446	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5205709	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	71050324	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	74414036	USD
	us-gaap	Interest Expense InterestExpense	10995900	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	3924124	USD
	us-gaap	Interest Expense InterestExpense	11516103	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957804	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957804	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2983249	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	2908249	USD
CY2017Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	2025445	USD
CY2018Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	1950445	USD
	us-gaap	Inventory Write Down InventoryWriteDown	536000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2018Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-249555	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1455611	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54242	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27863	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10233298	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72462522	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-9816378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-25932761	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	388050413	USD
	us-gaap	Net Income Loss NetIncomeLoss	369416894	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-9816378	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-25932761	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	390379087	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	374688397	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2021	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11818	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5067	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	151454	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	7041039	USD
	us-gaap	Operating Expenses OperatingExpenses	24835093	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	102190175	USD
	us-gaap	Operating Expenses OperatingExpenses	114843926	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5650785	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13978492	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	368885149	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	360640548	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	977353	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1607037	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	702167	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1095199	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	840253	USD
CY2018Q3	us-gaap	Other Liabilities OtherLiabilities	903953	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	54242	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	27863	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	84000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	239309000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	193052	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1708290	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2019999	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1134925	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27497	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	252679	USD
CY2018Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6000000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6007847	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3485378	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3341734	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	138640	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	117864	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2470835	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13899162	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3723198	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10043205	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10701305	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4095369	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6542448	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10138890	USD
CY2017Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	10408810	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10701305	USD
CY2018Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	4095369	USD
CY2016Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	17333332	USD
CY2017Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9430016	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6542448	USD
CY2018Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	14149000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	814622000	USD
CY2018Q3	us-gaap	Restructuring Reserve RestructuringReserve	589462000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-537375776	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-168182195	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	200000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1390254	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10856601	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	471075324	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	475484474	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	60200000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3093926	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9022039	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3114678	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9051617	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	773671	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1866279	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	52473805	USD
CY2017Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	11466162	USD
CY2018Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10729818	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78908929	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78842611	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82929476	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82744227	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78908929	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78842611	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80023044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79650373	shares

Files In Submission

Name	View Source	Status
0001010086-18-000014-index-headers.html	Edgar Link	pending
0001010086-18-000014-index.html	Edgar Link	pending
0001010086-18-000014.txt	Edgar Link	pending
0001010086-18-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20180930.xml	Edgar Link	completed
siga-20180930.xsd	Edgar Link	pending
siga-20180930x10q.htm	Edgar Link	pending
siga-20180930_cal.xml	Edgar Link	unprocessable
siga-20180930_def.xml	Edgar Link	unprocessable
siga-20180930_lab.xml	Edgar Link	unprocessable
siga-20180930_pre.xml	Edgar Link	unprocessable
siga-exhibit1052018q3.htm	Edgar Link	pending
siga-exhibit1062018q3.htm	Edgar Link	pending
siga-exhibit1072018q3.htm	Edgar Link	pending
siga-exhibit3112018q3.htm	Edgar Link	pending
siga-exhibit3122018q3.htm	Edgar Link	pending
siga-exhibit3212018q3.htm	Edgar Link	pending
siga-exhibit3222018q3.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2018 Q4 Form 10-Q Financial Statement

#000101008618000014 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2018 Q4 Form 10-Q Financial Statement

#000101008618000014 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga